On October 14, 2020, Hangzhou Fazheluo Biotechnology Co., Ltd. went to Nanjing to participate in the 85th API China Pharmaceutical Exhibition. This Nanjing API covers more than 50, 000 products in 24 categories, covering APIs, drugs, medical devices, chemical reagents, analytical instruments, glass instruments, laboratory equipment, pharmaceutical equipment, packaging materials, Chinese medicinal materials, health products, cosmetic raw materials and pharmaceutical industry-related technologies, with a wide coverage!

Hangzhou Fazheluo Biotechnology Co., Ltd., as a high-quality supplier of APIs, owns 2-amino-2-deoxy-D-galactosamine hydrochloride (CAS: 1772-03-8), a key raw material for RNAi drugs, the most popular product in the world. At the same time, it also produces a variety of best-selling products such as minoxidil, suvorexan, levetiracetam and other raw materials and their intermediates.

Under the influence of the COVID-19 epidemic, the company responded to the policy of reducing outdoor activities and tried its best to maintain customer relationships through remote work. Therefore, this exhibition is particularly rare. Taking this opportunity, the company has conducted in-depth face-to-face communication and exchanges with many new and old customers. Participating in this exhibition has also broadened new ideas for the company's project development and created new ways for product cooperation.